An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized TrialMasahiro Natsuaki, Takeshi Kimura, Takenori Domei et al.|Circulation|2023Cited by 145
Effects of Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure: A Randomized Trial (CANDLE)Atsushi Tanaka, Koichi Node, Masataka Sata et al.|ESC Heart Failure|2020Cited by 109
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trialHirotoshi Watanabe, Takeshi Kimura, Takenori Domei et al.|European Heart Journal|2024Cited by 37